Prelude Therapeutics, Inc. (PRLD)

2.89 +0.12 (+4.33%) USD  |  NASDAQ  |  Feb 24, 16:00
2.89 0.00 (0.00%) After-Hours: 17:27
More

Prelude Therapeutics Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for PRLD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
BioLife Solutions, Inc. Upgrade
Immunome, Inc. Upgrade
Incyte Corp. Upgrade
Aclaris Therapeutics, Inc. Upgrade
Relay Therapeutics, Inc. Upgrade